[Federal Register Volume 84, Number 241 (Monday, December 16, 2019)]
[Notices]
[Pages 68473-68474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27093]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-564]


Importer of Controlled Substances Application: Meridian Medical 
Technologies

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 15, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before January 15, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on November 13, 2019, Meridian Medical Technologies, 
2555 Hermelin Drive, Saint Louis, Missouri 63144 applied to be 
registered as an importer of the following basic class of controlled 
substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Morphine...............................    9300   II
------------------------------------------------------------------------

    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world. The company has been asked to ensure that its product, which is 
sold to European customers, meets the standards established by the 
European Pharmacopeia, administered by the

[[Page 68474]]

Directorate for the quality of Medicines (EDQM). In order to ensure 
that its product will meet European specifications, the company seeks 
to import morphine supplied by EDQM for use as reference standards.

    Dated: December 2, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-27093 Filed 12-13-19; 8:45 am]
 BILLING CODE 4410-09-P